\-\ Texto\\:\\ \ \(0\)\
\-\ tumor\\ was\\ initially\\ treated\\ on\\ daily\\ carboplatin\\ and\\ weekly\\ vincristine\\ with\\ craniospinal\\ irradiation\\.\\ subsequent\\ decrease\\ in\\ the\\ size\\ of\\ lesion\\ occurred\\ then\\ re\\-resection\\.\\ patient\\ then\\ received\\ stereotactic\\ radiotherapy\\.\\ ultimately\\,\\ patient\\ underwent\\ high\\-dose\\ chemotherapy\\ with\\ cytoxan\\ and\\ melphalan\\ with\\ autologous\\ stem\\ cell\\ rescue\\.\ \(0\)\
\-\ there\\ is\\ a\\ large\\ heterogeneous\\ mass\\ in\\ the\\ pineal\\ region\\ causing\\ severe\\ hydrocephalus\\ of\\ the\\ lateral\\ and\\ third\\ ventricles\\.\ \(0\)\
\-\ the\\ lobular\\ mass\\ is\\ iso\\ \\-\\ to\\ hypointense\\ on\\ t1\\-weighted\\ imaging\\ and\\ iso\\-\\ to\\ hypointense\\ on\\ t2\\ weighted\ \(0\)\
\-\ imaging\\ with\\ intense\\ enhancement\\ of\\ most\\ of\\ the\\ mass\\.\ \(1\)\
\-\ medulloepithelioma\ \(1\)\
\-\ pineoblastoma\ \(3\)\
\-\ non\\ germinomatous\\ germ\\ cell\\ tumor\ \(0\)\
\-\ pnet\ \(0\)\
\-\ presents\\ with\\ headache\\ and\\ vomiting\ \(0\)\
\-\ pt\\ is\\ alive\\ 2\\ years\\ from\\ time\\ of\\ presentation\\/resection\\.\\ \\ there\\ is\\ a\\ stable\\ cranial\\ nerve\\ iii\\ palsy\\ bilaterally\\ and\\ cognitive\\ difficulties\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ iso\\:\\ 0\\.23967205117802154\ \(0\)\
\-\ hypointense\\:\\ 0\\.1885278039772011\ \(0\)\
\-\ craniospinal\\:\\ 0\\.17130388276400865\ \(0\)\
\-\ melphalan\\:\\ 0\\.17130388276400865\ \(0\)\
\-\ germinomatous\\:\\ 0\\.17130388276400865\ \(0\)\
\-\ medulloepithelioma\\:\\ 0\\.1636900052332544\ \(0\)\
\-\ weighted\\:\\ 0\\.1598013516522787\ \(0\)\
\-\ carboplatin\\:\\ 0\\.1540976539775013\ \(0\)\
\-\ cytoxan\\:\\ 0\\.1540976539775013\ \(0\)\
\-\ then\\:\\ 0\\.15165274283148042\ \(0\)\
\-\ rescue\\:\\ 0\\.15067399562346284\ \(0\)\
\-\ alive\\:\\ 0\\.15067399562346284\ \(0\)\
\-\ pineoblastoma\\:\\ 0\\.13929189718120039\ \(0\)\
\-\ autologous\\:\\ 0\\.1361549334420214\ \(0\)\
\-\ and\\:\\ 0\\.13280687211030037\ \(0\)\
\-\ irradiation\\:\\ 0\\.132255853934634\ \(0\)\
\-\ weekly\\:\\ 0\\.1311174367524199\ \(0\)\
\-\ stereotactic\\:\\ 0\\.127149446589657\ \(0\)\
\-\ vincristine\\:\\ 0\\.12627588757140884\ \(0\)\
\-\ cognitive\\:\\ 0\\.1238754155812024\ \(0\)\
\-\ mass\\:\\ 0\\.12274784763911775\ \(0\)\
\-\ cell\\:\\ 0\\.12255206191511517\ \(0\)\
\-\ difficulties\\:\\ 0\\.1217473145106197\ \(0\)\
\-\ pineal\\:\\ 0\\.11810142714262833\ \(0\)\
\-\ is\\:\\ 0\\.11733920182629265\ \(0\)\
\-\ radiotherapy\\:\\ 0\\.11601281742732898\ \(0\)\
\-\ pnet\\:\\ 0\\.11504962514812662\ \(0\)\
\-\ stem\\:\\ 0\\.11325987796161727\ \(0\)\
\-\ imaging\\:\\ 0\\.11258753285994137\ \(0\)\
\-\ tumor\\:\\ 0\\.11205712595003088\ \(0\)\
\-\ ultimately\\:\\ 0\\.11202131050192302\ \(0\)\
\-\ lobular\\:\\ 0\\.10873130490082812\ \(0\)\
\-\ palsy\\:\\ 0\\.10712535819493209\ \(0\)\
\-\ the\\:\\ 0\\.106868913899004\ \(0\)\
\-\ with\\:\\ 0\\.1048745328638219\ \(0\)\
\-\ of\\:\\ 0\\.10481190777390229\ \(0\)\
\-\ occurred\\:\\ 0\\.10349758769522126\ \(0\)\
\-\ daily\\:\\ 0\\.10156993438694165\ \(0\)\
\-\ intense\\:\\ 0\\.10111742737007384\ \(0\)\
\-\ germ\\:\\ 0\\.10003168380589311\ \(0\)\
\-\ on\\:\\ 0\\.09705379003422966\ \(0\)\
\-\ ventricles\\:\\ 0\\.09410934858514051\ \(0\)\
\-\ received\\:\\ 0\\.09320782510525931\ \(0\)\
\-\ iii\\:\\ 0\\.09248826839352312\ \(0\)\
\-\ decrease\\:\\ 0\\.0920694079230452\ \(0\)\
\-\ causing\\:\\ 0\\.08798997451024257\ \(0\)\
\-\ cranial\\:\\ 0\\.08755069991765302\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.08744246830669757\ \(0\)\
\-\ there\\:\\ 0\\.08524328274784378\ \(0\)\
\-\ stable\\:\\ 0\\.0847337300364033\ \(0\)\
\-\ initially\\:\\ 0\\.0840008318445207\ \(0\)\
\-\ third\\:\\ 0\\.08156086849903091\ \(0\)\
\-\ subsequent\\:\\ 0\\.08109333897534896\ \(0\)\
\-\ vomiting\\:\\ 0\\.0792616606976923\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.07752911551603404\ \(0\)\
\-\ pt\\:\\ 0\\.07708873711739266\ \(0\)\
\-\ nerve\\:\\ 0\\.0764169273967721\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.07606036986443515\ \(0\)\
\-\ headache\\:\\ 0\\.07384208492718586\ \(0\)\
\-\ underwent\\:\\ 0\\.07378985086703496\ \(0\)\
\-\ size\\:\\ 0\\.07252910014130405\ \(0\)\
\-\ bilaterally\\:\\ 0\\.07143952078249936\ \(0\)\
\-\ patient\\:\\ 0\\.0696797607874611\ \(0\)\
\-\ severe\\:\\ 0\\.0678098845038098\ \(0\)\
\-\ treated\\:\\ 0\\.06670496979705913\ \(0\)\
\-\ years\\:\\ 0\\.06566147176816807\ \(0\)\
\-\ region\\:\\ 0\\.0640727275076011\ \(0\)\
\-\ time\\:\\ 0\\.0634911251622957\ \(0\)\
\-\ enhancement\\:\\ 0\\.06165485339427016\ \(0\)\
\-\ t2\\:\\ 0\\.06162753974215822\ \(0\)\
\-\ most\\:\\ 0\\.05574708676771528\ \(0\)\
\-\ large\\:\\ 0\\.05367108476229449\ \(0\)\
\-\ to\\:\\ 0\\.05355822935389042\ \(0\)\
\-\ in\\:\\ 0\\.053294615859933475\ \(0\)\
\-\ lateral\\:\\ 0\\.053159963726489116\ \(0\)\
\-\ presents\\:\\ 0\\.05152895064253951\ \(0\)\
\-\ lesion\\:\\ 0\\.05135441667996795\ \(0\)\
\-\ non\\:\\ 0\\.05082498152390005\ \(0\)\
\-\ from\\:\\ 0\\.04254245039723662\ \(0\)\
\-\ was\\:\\ 0\\.03733143968301048\ \(0\)\
